Physician

Rajesh Kukunoor, M.D.

According to 2025 Medicare claims, Rajesh Kukunoor, M.D. (NPI: 1346214384) practices hematology/oncology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is IRONWOOD PHYSICIANS, PC (NPI: 1740269299; TIN: 731636831) and primary practice location at 85260-6746. Kukunoor is affiliated with the Banner Health Network (ACO ID: A3229) and Commonwealth Primary Care ACO LLC (ACO ID: D0224), participating under both the MSSP and REACH models.

Kukunoor's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 913 traditional Medicare patients, billed 233,060 HCPCS/CPT codes, and received $3,825,039 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,557 prescription claims across 296 beneficiaries totaling $3,854,296 in drug costs, led by Revlimid (Lenalidomide). 2022 DME data shows 24 claims. Open Payments data shows 96 records totaling $30,712. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	748	151,515	$2,190,243
2016	836	240,496	$2,731,868
2017	762	202,841	$2,881,186
2018	736	284,054	$3,671,922
2019	698	312,248	$4,051,584
2020	686	287,477	$4,267,963
2021	701	272,854	$4,145,198
2022	692	214,219	$3,521,648
2023	792	197,835	$3,275,855
2024	913	233,060	$3,825,039

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	275	1,856	$2,001,087
2016	282	1,780	$2,813,567
2017	303	2,134	$3,800,789
2018	343	2,322	$4,522,023
2019	346	2,198	$4,767,313
2020	338	2,102	$5,169,319
2021	337	2,009	$5,625,420
2022	319	1,783	$5,552,847
2023	289	1,598	$4,072,720
2024	296	1,557	$3,854,296

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	71	395	$49,939
2016	12	197	$34,960
2017	11	96	$23,560
2018	N/R	46	$8,574
2019	N/R	42	$4,051
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	24	$2,517
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	121	121	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	303	439	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	490	885	$62
96372	Injection of drug or substance under skin or into muscle	106	404	$11
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	104	10,378	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	50	1,400	$957,544
Lenalidomide	Lenalidomide	60	1,680	$790,937
Pomalyst	Pomalidomide	29	812	$746,795
Venclexta	Venetoclax	19	570	$302,665
Imbruvica	Ibrutinib	12	360	$165,720

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	96	$30,712	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rajesh Kukunoor, M.D.?

Tedicare shows public-source Medicare data for Rajesh Kukunoor, M.D. (NPI 1346214384), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajesh Kukunoor, M.D. have ACO affiliation data?

Rajesh Kukunoor, M.D. is shown with ACO affiliation data for Banner Health Network (MSSP, ACO ID A3229) and Commonwealth Primary Care ACO LLC (REACH, ACO ID D0224).

What billing organization is linked to Rajesh Kukunoor, M.D.?

Rajesh Kukunoor, M.D. is linked to IRONWOOD PHYSICIANS, PC (billing NPI 1740269299) in the available physician profile data.

Does Rajesh Kukunoor, M.D. have Open Payments data?

Rajesh Kukunoor, M.D. has 96 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.